Japanese startup PorMedTec says it’s have cloned three piglets with the express purpose of having their organs be viable for transplantation to humans, without being rejected by the immune system.
The company imported gene-edited cells from a US biotech startup called eGenesis and used them to create genetically modified embryos, the Japan Times reports, which were then implanted into the uterus of a pig.
“The realization of xenotransplantation has been long awaited in Japan for several years, but it remained in the basic research stage because pigs that could withstand clinical application were still under development,” the company said in a statement.
Comments are closed.